A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Based on what 155 years of historic precedent tells us about notable declines in M2 and the performance of the U.S. economy ...

Postpartum depression, a serious mental health condition,​ isn't just something new moms​ can struggle with — studies show ...

A study shows that vegans are at greater risk of being depressed because of milk alternatives they choose. But a Washington, ...

Recent study shows alarming links between retirement and depression, with expert advice on recognizing warning signs and ...

A compelling new study is building on a growing body of evidence showing a common exercise supplement used to build muscle ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

A new study found that retirees who drank moderately had fewer depression symptoms than non-drinkers, but retirees who drank ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

People receiving talking therapy for mild to severe depression reported greater improvements to their symptoms when also taking creatine compared with those on a placebo ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.